Late yesterday, the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) lifted their recommended pause on the use of Johnson & Johnson’s COVID-19 Vaccine. The NJ Department of Health is in the process of notifying vaccination sites across the state and plans to provide them with the updated CDC and FDA guidance regarding the Johnson & Johnson COVID-19 Vaccine. 

The NJDOH has said that vaccination sites will be provided with the updated fact sheets accompanying the vaccine, which indicates that women under the age of 50 should be aware of the risk of a rare blood clotting syndrome associated with the vaccine. Health care providers administering the vaccine and vaccine recipients or caregivers should review the Johson & Johnson COVID-19 Vaccine Fact Sheet for Healthcare Providers Administering the Vaccine and the Fact Sheet for Recipients and Caregivers. These documents have been revised to include information about the risk of thrombosis-thrombocytopenia syndrome, which has occurred in a very small number of people who have received the Johnson & Johnson COVID-19 Vaccine.

If you have questions regarding risks associated with the Johnson & Johnson COVID-19 Vaccine, please refer to the CDC and FDA websites and contact your healthcare provider. 

Hope you had a chance to enjoy the beautiful weather today and have a great rest of your weekend!

Sarah Nebart

Mayor, Mendham Township